The IER5 gene was included in this analysis, and as shown in Fig. S1C, there was no association of the IER5 gene with a super enhancer in the 6 blood cancer-derived cell lines we examined, but there was an association in 5 of the 12 solid cancer-derived cell lines, regardless of p53 status. The gene discussed is IER5; the disease is hematopoietic and lymphoid system neoplasm.